Your browser doesn't support javascript.
loading
Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development.
Takai, Yoshiki; Misu, Tatsuro; Nishiyama, Shuhei; Ono, Hirohiko; Kuroda, Hiroshi; Nakashima, Ichiro; Saito, Ryuta; Kanamori, Masayuki; Sonoda, Yukihiko; Kumabe, Toshihiro; Mugikura, Shunji; Watanabe, Mika; Aoki, Masashi; Fujihara, Kazuo.
Afiliação
  • Takai Y; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Misu T; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Nishiyama S; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Ono H; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Kuroda H; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Nakashima I; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Saito R; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Kanamori M; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Sonoda Y; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Kumabe T; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Mugikura S; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Watanabe M; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Aoki M; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
  • Fujihara K; From the Departments of Neurology (Y.T., T.M., S.N., H.O., H.K., I.N., M.A., K.F.), Multiple Sclerosis Therapeutics (T.M., K.F.), Neurosurgery (R.S., M.K.), Diagnostic Radiology (S.M.), and Pathology (M.W.), Tohoku University Graduate School of Medicine, Sendai; Department of Neurology (T.M.), Natio
Neurology ; 87(19): 2000-2005, 2016 Nov 08.
Article em En | MEDLINE | ID: mdl-27733565
ABSTRACT

OBJECTIVE:

To clarify the pathogenic factors and mechanisms underlying the development of concentric demyelinating lesions in Balo disease.

METHODS:

We conducted serial clinical, MRI, and histopathologic assessments of concentric lesion formation in a case of relapsing Balo disease.

RESULTS:

The patient experienced 2 attacks caused by left parietal and left frontal lesions in 5 years. In MRI findings from both episodes of expanding lesions, there were diffusion-restricted rings that antedated the appearance of gadolinium enhancement; subsequently, typical concentric T2 lesions appeared concurrently with the disappearance of this enhancement. Histopathologic examinations of biopsied brain tissues revealed definite concentric demyelinating layers typical of Balo disease with massive macrophage infiltration but preserved axons. Numerous hypertrophic astrocytes were observed beyond the edges of and within the demyelinating layers. The expression of hypoxia-inducible factor-1α, a protein related to hypoxia-induced tissue preconditioning that contributes to survival and protection against further hypoxia-like injury, was upregulated primarily in glial cells located beyond the edge of the demyelinating layers but was also elevated in hypertrophic astrocytes on the inner sides of resected lesions and in oligodendrocytes in nondemyelinating layers. In addition, these astrocytes expressed CC motif chemokine 2 and/or interleukin-1ß, which are inducible by hypoxia-inducible factor-1α and potentially promote demyelination.

CONCLUSIONS:

Our study suggests that a unique interplay between hypoxia-induced tissue preconditioning and proinflammatory cytokines derived from glial cells may contribute to the development of concentric demyelinating lesions in Balo disease.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Cerebral Difusa de Schilder / Neuroglia / Bainha de Mielina Limite: Humans / Male / Middle aged Idioma: En Revista: Neurology Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Cerebral Difusa de Schilder / Neuroglia / Bainha de Mielina Limite: Humans / Male / Middle aged Idioma: En Revista: Neurology Ano de publicação: 2016 Tipo de documento: Article